Selective Delivery of an Anticancer Drug with Aptamer-Functionalized Liposomes to Breast Cancer Cells in Vitro and in Vivo.
about
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications.Aptamers: A promising chemical antibody for cancer therapyProgress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery SystemsNucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical SensingDNA Aptamers in the Diagnosis and Treatment of Human DiseasesAptamer-Mediated Targeted Delivery of Therapeutics: An UpdatessDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 CellsMultimodal Detection of a Small Molecule Target Using Stimuli-Responsive Liposome Triggered by Aptamer-Enzyme ConjugateLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.DNA Aptamer Technology for Personalized Medicine.Progress in aptamer-mediated drug delivery vehicles for cancer targeting and its implications in addressing chemotherapeutic challenges.Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicineApplications of synchrotron-based spectroscopic techniques in studying nucleic acids and nucleic acid-functionalized nanomaterialsAptamers: active targeting ligands for cancer diagnosis and therapyAS1411-conjugated gold nanospheres and their potential for breast cancer therapyPolydopamine-Based Surface Modification of Novel Nanoparticle-Aptamer Bioconjugates for In Vivo Breast Cancer Targeting and Enhanced Therapeutic Effects.Oligonucleotide aptamers: new tools for targeted cancer therapy.Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.Application of aptamers in diagnostics, drug-delivery and imaging.The Effects of Spacer Length and Composition on Aptamer-Mediated Cell-Specific Targeting with Nanoscale PEGylated Liposomal Doxorubicin.Aptamers and their applications in nanomedicine.Multifunctional nanoparticles: recent progress in cancer therapeutics.Advanced Functional Nanomaterials for Theranostics.In vitro study of novel gadolinium-loaded liposomes guided by GBI-10 aptamer for promising tumor targeting and tumor diagnosis by magnetic resonance imaging.Single molecular recognition force spectroscopy study of a DNA aptamer with the target epithelial cell adhesion molecule.Surface functionalization of polymeric nanoparticles for tumor drug delivery: approaches and challenges.Advances in the development of aptamer drug conjugates for targeted drug delivery.Self-Assembled Aptamer-Nanomedicine for Targeted Chemotherapy and Gene Therapy.In Situ Spatial Complementation of Aptamer-Mediated Recognition Enables Live-Cell Imaging of Native RNA Transcripts in Real Time.A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes.A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor Cells.Inhibition of DNA replication by an anti-PCNA aptamer/PCNA complex.Cytotoxicity of guanine-based degradation products contributes to the antiproliferative activity of guanine-rich oligonucleotides.Current Advances in Aptamers for Cancer Diagnosis and Therapy.5TR1 aptamer-PEGylated liposomal doxorubicin enhances cellular uptake and suppresses tumour growth by targeting MUC1 on the surface of cancer cells.Supramolecular aptamer nano-constructs for receptor-mediated targeting and light-triggered release of chemotherapeutics into cancer cells.Single-trigger dual-responsive nanoparticles for controllable and sequential prodrug activation.Aptamer-mediated selective delivery of a cytotoxic cationic NHC-Au(i) complex to cancer cells.Betulin-3,28-diphosphate as a Component of Combination Cytostatic Drugs for the Treatment of Ehrlich Ascites Carcinoma In Vitro and In Vivo Experiments.
P2860
Q26744835-3E498DEF-8ABB-4F05-A7C2-5DA333BBB1BAQ26766832-29366F9B-CC9D-43E6-91D7-E19D73740C5FQ26782485-A7871436-BE6C-4F5B-8D93-6EAABE77CA84Q26825644-D347AD65-1094-45AA-A63B-80276FA0C60FQ26864314-F3A207FF-E5DD-4740-ADD1-9B7C030E8091Q28066827-23A208C3-2A47-41A1-8AB4-2068ECFE8BC6Q28552859-512F0BDD-069A-4F48-8F86-813D320EAC1AQ30365838-79EA0118-8DDB-4598-9965-DFC326D21158Q30366990-9B7A8D25-7B6C-4396-9995-EAAB0A9A8078Q30412965-70B95FD4-D7C1-4690-956A-521D2A738C23Q33935498-90A418DC-4789-4440-A652-D513A3FA2860Q34698624-7E47E987-4108-4E35-A05C-AA4BAD2A33A2Q34766893-4290D8AA-8D2B-4D5A-AB97-713866E3B63CQ35086493-7D2F51CA-4F84-4889-A2B7-D260D357980BQ36355940-C95703DC-2295-45C1-91B2-7BCB6D202E8BQ36644318-6B3E0432-1903-4486-84F8-1A5C819A5663Q38237132-EA1381B5-AD1A-4708-BFD4-FA86DFA6F6B8Q38272165-93CFD03A-E0D1-4EA3-A3BF-3D172151F683Q38291061-0A47D221-B251-4DF7-A1F4-BECD4A0985ACQ38292678-F49F4DB5-E504-498B-AA38-70CF13D65D14Q38353973-FFA95453-4ABF-409E-AEC1-CA066549DBEEQ38559193-02A50648-6723-4AC0-A59A-546ADBF90BE3Q38639877-77C40AAD-3AFF-43F7-A2BE-56614A231B74Q38840049-0ACA70B2-7461-40B8-B823-48CD202ACFFDQ38847604-1AB9927D-E93D-4E4B-9CB1-374A8215B7ADQ38899902-08B56A04-FE03-4C40-B73F-42C706297776Q38995729-2A341CF8-D605-45A5-AB03-307D6EDCCE7DQ45875443-DC887C31-3F6F-4F42-A99F-2F69C38BD911Q46103261-4F67F3FB-9277-461D-8FC8-D8F6BE164291Q47150459-5DBECCBD-6984-40CD-A256-3A071166A65BQ47207633-3CA26C2B-F55D-47C4-B2DE-7331F7D7796EQ47351886-88EC71A3-152C-40D6-8BA6-327259998C8BQ47428247-72BC79C3-552F-4D38-ACB7-EC591F638DEFQ47561686-9F72E9EE-5F3E-49AC-B125-38D5EAE1F43FQ48581486-6D8C6774-BBFE-47FF-B5E3-DD3B5693F876Q49424319-DB055C0E-2E0B-4974-92AC-8110AEBF5357Q50543302-2FAC5B51-C7F3-4F20-89A1-3D392C954EB0Q52421731-F74A8C0F-4925-48D5-B801-535BDAF4AAF7Q55397401-3C50CF31-A2CA-4E52-BB63-5015D991CBB6
P2860
Selective Delivery of an Anticancer Drug with Aptamer-Functionalized Liposomes to Breast Cancer Cells in Vitro and in Vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Selective Delivery of an Antic ...... er Cells in Vitro and in Vivo.
@en
Selective Delivery of an Antic ...... er Cells in Vitro and in Vivo.
@nl
type
label
Selective Delivery of an Antic ...... er Cells in Vitro and in Vivo.
@en
Selective Delivery of an Antic ...... er Cells in Vitro and in Vivo.
@nl
prefLabel
Selective Delivery of an Antic ...... er Cells in Vitro and in Vivo.
@en
Selective Delivery of an Antic ...... er Cells in Vitro and in Vivo.
@nl
P2093
P2860
P50
P356
P1476
Selective Delivery of an Antic ...... cer Cells in Vitro and in Vivo
@en
P2093
Jianjun Cheng
John A Katzenellenbogen
Kevin Hwang
Ngo Yin Wong
Norio Yasui
Wendan Wang
William G Helferich
Xujuan Yang
P2860
P304
P356
10.1039/C3TB20412J
P407
P577
2013-10-01T00:00:00Z